top of page
    MEMO logo_purple_PNG-transparent.png

    Transforming Epilepsy Research and Drug Discovery 

    Modular Platform for Epilepsy Modelling (MEMO) offers best-in class solution for seizure activity detection and epilepsy modelling  in vitro

    arvo 160622 JR 54.jpg

    Advanced, Humanized and Cell-based

    Modular Platform for Epilepsy Modelling in vitro

     MEMO platform is devoted to solve following challenges

    arvo 160622 JR 40.jpg

    Finding novel approaches to discover truly innovative anti-seizure medicatons

    arvo 160622 JR 42.jpg

    Accomplish CNS safety testing for seizure liability early enough during drug discovery

    arvo 160622 JR 49.jpg

    Advancing tools to reveal  disease mechanisms of epilepsies

    MEMO platform

    MEMO whole device (1)_edited.png
    Gas supply chamber
    Medium Reservoirs
    Microfluidic device
    Microelec-trode array

    Microfluidic device 

    arvo 160622 JR 32_edited.jpg

    Three-compartment microfluidic device enables formation of axonally connected brain-like circuitry of neuronal networks 

    arvo 160622 JR 32_edited.jpg

    Microelectrode Array

    Customized microelectrode array

     enables the neuronal network and seizure-like activity measurements

    coeboc arvo 160322 JR 100_edited.jpg

    Data Analysis

    MEA data is analyzed by

    our own smart algorithms

    About Us 

    MEMO is an advanced platform technology innovated in a project owned by Tampere University, Finland. MEMO platform bases on the strong and impactful neuroscientific and microfabrication technology backgrounds of NeuroGroup (led by Adj. Prof Susanna Narkilahti) and Micro- and Nanosystems Research group (led by Prof Pasi Kallio). 

     

    MEMO project is a Research to Business project, aiming to the commercialization of research results and is funded by Business Finland.

    arvo 160622 JR 27.jpg
    Tampere_University_logo.png
    businessfinland_logo.jpg

    MEMO project team

    Our team has over 15 years of experience in combining neuroscience and engineering technologies.  We have excellent hands-on expertise of human pluripotent stem cells, neuronal cultures, microfluidics, microelectrode arrays and data analysis. MEMO project has a comprehensive steering group from the fields of business and engineering technologies as well as epilepsy and drug R&D research.

    Susanna Narkilahti

    Adj. Prof. Neuroscience Specialist, stem cells, in vitro models 

    arvo 160622 JR 18_edited.jpg

    Satu Jäntti

    MSc, Business Champion, Cell Technology Scientist

    arvo 160622 JR 15_edited.jpg

    Jouni Sirviö

    PhD, Senior Expert, Neuroscience, Drug development

    arvo 160622 JR 19_edited.jpg

    Hanna Mäkelä

    Laboratory Specialist

    arvo 160622 JR 11_edited.jpg

    Pasi Kallio

    Prof. Engineering Specialist, Nano- and microfluidic systems

    arvo 160622 JR 23_edited.jpg

    Lassi Sukki

    MSc, Microfluidic and Microfabrication Specialist 

    Lassisukki.jfif

    Timo Salpavaara

    PhD,  Sensors and Electronics Specialist, Microfabrication

    _720662864.JPEG

    Anna Vallius

    Coordinator

    arvo 160622 JR 10_edited_edited.jpg
    Picture1.jpg

    Clinical advisor

    Jukka Peltola, 

    Prof. of Neurology, 

    Chief Physician

    Want to know more?  Interested in collaboration? 

    Project Leader

    Susanna Narkilahti

    susanna.narkilahti(at)tuni.fi

    Business Champion

    Satu Jäntti

    satu.jantti(at)tuni.fi

    Kauppi Campus

    Tampere University 

    Arvo Ylpön Katu 34

    33520 Tampere, Finland

    bottom of page